Wells Fargo Adjusts Healthpeak Properties Price Target to $19 From $22

Wells Fargo reduced its price target for Healthpeak Properties from $22 to $19. The stock is currently trading at $18.82, down 0.84% on the day but up 18.03% year-to-date. Barclays also recently lowered its target to $21 from $24.

Original reporting
Published Oct 19, 2026, 1:14 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 19, 2026, 1:36 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
MARKET
Neutral
AI market analysis
Mentioned
$DOC
Relevance
5/10
AlphAI data visualization · based on marketscreener.com
Decision brief

The 30-second read

Low
01

Why it matters

Analyst target changes can influence short‑term price movement but lack material new corporate events.

02

Market read

Limited relevance; primarily of interest to traders tracking analyst revisions.

03

What to watch

Recent lease renewals or occupancy improvements not mentioned.

Relevance 5/10Novelty 4/10Timing: pre‑market today

Background

The article reports a price‑target adjustment by Wells Fargo with no additional company news.

Market effects

May slightly dampen sentiment in the REIT/healthcare property sector.

Limited to U.S. REIT investors.

Minimal global impact.

Counterpoint

The target cut could be an overreaction; the stock may be undervalued.

Key entities

  • Healthpeak Properties

    U.S. REIT focused on health‑care real estate.

  • Wells Fargo

    Equity research firm issuing the target change.

Related articles

$CCIMed

Better High-Yield Dividend Stock: Crown Castle vs. Healthpeak

Crown Castle (CCI) and Healthpeak Properties (PEAK) both raised 2026 outlooks in Q2. CCI yields 5.4% with a 93% AFFO payout ratio for 2026, while PEAK yields 6.7% with a 78% ratio. CCI trades at 16x forward AFFO, PEAK at 12x. Both have cut dividends previously. CCI's Q2 AFFO rose to $1.13/share, with full-year outlook at $4.53-$4.65.

$DOCMedAI 8/10

Healthpeak (DOC) Turns Portfolio Sales Into Fatter 2026 Guidance

Healthpeak Properties (DOC) raised its 2026 guidance, citing strong performance in outpatient medical and lab leasing, and significant growth at its senior housing operator, Janus Living (JAN). The company reported $0.46 FFO per share, flat year-over-year, and used asset sales to reduce debt and fund buybacks. Lab segment NOI declined, and leverage remains at 4.7x EBITDAre.

$DOCMed

Healthpeak Properties Q2 Earnings Call Highlights

Healthpeak Properties (NYSE:DOC) highlighted Q2 results and updates on capital recycling and leasing. It recapitalized a Brookfield outpatient portfolio, retaining 51% interest and raising $1B cash, and noted a 5.9% trailing cash cap rate. Lab occupancy rose to 78.5%. Net debt/adj. EBITDA was 4.7x with $4.1B liquidity; it repaid $900M debt and repurchased $100M shares.

$DOCMed

Is Wall Street Bullish or Bearish on Healthpeak Properties Stock?

Healthpeak Properties (DOC) is a U.S. healthcare REIT with a $14.9B market cap. The stock rose 31.8% over the past year and nearly 41% in 2026. After Q2 2026 results on Aug. 4, revenue was $771.6M and adjusted FFO was $0.46, both above estimates. Full-year FFO guidance is $1.73 to $1.77. Analysts rate DOC a “Moderate Buy,” with Barclays holding a $23 target.

$DOCLow

Healthpeak Properties Reports Second Quarter 2026 Results and Increases Full Year 2026 Earnings Guidance

HEALTHPEAK PROPERTIES, INC. (DOC) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Healthpeak Properties Reports Second Quarter 2026 Results and Increases Full Year 2026 Earnings Guidance DENVER, August 4, 2026 - Healthpeak Properties, Inc. (NYSE: DOC) ("Healthpeak"), a leading owner, operator, and developer of real estate for healthcare discovery